Project Grant R34MH139436
- This Project Grant award of $383,791 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to integrate a pharmacy technician-based model for delivering long-acting injectable HIV treatment (LA-CAB/RPV) into community-based Federally Qualified Health Centers (FQHCs) that serve underserved populations with HIV. The key products/services to be delivered include: Adapting and refining the pharmacy technician-based LA-CAB/RPV...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- This $691,620 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop a web-based intervention to promote pre-exposure prophylaxis (PrEP) awareness and demand among women in the Southeastern United States. The project involves three key components: Developing a social media targeting approach to engage women with indications of PrEP need. This will include focus group discussions and a social media...
- The National Institute of Mental Health (NIMH) awarded a $294,408 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Medical College of Wisconsin, Inc. The grant will fund a 3-year research project to understand patient-level implementation determinants related to long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young men who have sex with men living in rural areas. The research will also explore HIV testing, HIV care engagement, and the...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will provide $819,998 to the University of Chicago to test the impact of a basic income guarantee on viral suppression and clinic engagement for young people living with HIV in Chicago. The 5-year project, starting on August 6, 2025, will: 1) provide $500 monthly basic income payments to a randomized group, 2) measure outcomes like viral...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $881,439 in funding to the University of North Carolina at Chapel Hill to conduct research on the evolution and latency of HIV in people infected with the subtype C virus. The key objectives of the project are to: determine the frequency of macrophage-tropic virus evolution in the central nervous system (CNS); identify which cell types in the CNS...
- The University of North Carolina at Chapel Hill received a $1,414,502 Project Grant award on August 1, 2025 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct research on "Assessing Time-to-Treatment Variability in Antiretroviral Penetration by Multimodal Imaging." The research aims to investigate the role of pharmacology in the persistence of HIV virus within tissue reservoirs during antiretroviral...
- This $452,376 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to develop a predictive model for identifying HIV patients at risk of disengaging from medical care. The University of Chicago is conducting this 2-year project, which has two key objectives: Determine the performance of a Natural Language Processing (NLP) model for predicting loss to follow-up (LTFU) from HIV care across...
- This federal Project Grant award of $819,603 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant supports research to implement novel strategies for long-acting antiretroviral therapy (ART) delivery to people with criminal legal involvement (CLI), a population disproportionately impacted by HIV. The research aims to understand the dynamics of HIV care continuity for people with...
- The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...
This $684,765 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to evaluate field-based delivery of long-acting injectable antiretroviral therapy (LAI) for persons with HIV who are out of care in North Carolina. The key products and services to be delivered include: The award period runs from September 23, 2025 to September 22, 2028, with the University of North Carolina at Chapel Hill serving as the primary awardee. This study aims to rapidly engage and suppress HIV among persons known to be out of care, especially in the rural Southeastern U.S. where limited access to HIV care has resulted in poor health outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $684.8k | 9/23/25 |